Advertisement

Sources and Turnover Rates of Taurine in Newborn, Weanling, and Mature Rats

  • Ryan J. Huxtable
  • Shirley E. Lippincott
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 139)

Abstract

The pharmacology of taurine has received close study, and taurine has been shown to be beneficial in conditions as diverse as genetic cardiomyopathy (1), cardiac arrhythmias (2), and epilepsy (5). Deficiencies in taurine have also been associated with the development of such pathological processes as retinal degeneration in cats (9) and cardiomyopathy in humans (4). These investigations have linked taurine with various phenomena without yielding insight into the mechanism by which taurine is acting, or its normal functional involvement in cellular processes.

Keywords

Taurine Level Taurine Concentration Taurine Content Cysteine Sulfinate Decarboxylase Cysteine Sulfinate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Azari, J., Brumbaugh, P., and Huxtable, R., 1980, Prophylaxis by taurine in the hearts of cardiomyopathie hamsters, J. Mol. Cell. Cardiol, 12: 1353–1366.PubMedCrossRefGoogle Scholar
  2. 2.
    Chazov, E., Mal’Chikova, L., Lipina, N., Reshetnaya, N., Asafoy, G., and Smirnov, V., 1974, Taurine effect on the electrical activity of the heart, Kardiologiya 14 (7): 18–26.PubMedGoogle Scholar
  3. 3.
    Collins, G.G.S., 1974, The rates of synthesis, uptake, and disappearance of (14C) taurine in eight areas of the rat central nervous system, Brain Res, 76: 447–458.PubMedCrossRefGoogle Scholar
  4. 4.
    Darsee, J.R., and Heymsfield, S.B., 1981, Decreased myocardial taurine levels and hypertaurinuria in a kindred with mitral valve prolapse and congestive cardiomyopathy, New Eng. J. Med, 304; 129–135.PubMedCrossRefGoogle Scholar
  5. 5.
    Huxtable, R., and Laird, H., 1978, The prolonged anticonvulsant action of taurine on genetically determined seizure susceptibility, Can. J. Neurol. Sci, 5: 215–221.Google Scholar
  6. 6.
    Kaczmarek, L.K., A comparison of the evidence for taurine and GABA as neurotransmitters, in: “Taurine,” R. Huxtable and A. Barbeau, eds., Raven Press, New York (1976), pp. 283–292Google Scholar
  7. 7.
    Kibe, C., Wake, C., Kuramoto, T., and Hoshita, T., 1980, Effect of dietary taurine on bile acid metabolism in guinea pigs, Lipids, 15: 224–229.PubMedCrossRefGoogle Scholar
  8. 8.
    National Academy of Sciences: Nutrient Requirements of Domestic Animals, Washington, D.C., (1978).Google Scholar
  9. 9.
    Schmidt, S.Y., Berson, E.L., Hayes, K.C., 1976, Retinal degeneration in cats fed casein 1. Taurine deficiency, Invest. Ophthalmol, 15: 47–52.PubMedGoogle Scholar
  10. 10.
    Sturman, J.A., 1973, Taurine pool sizes in the rat: Effects of vitamin B-6 deficiency and high taurine diet, J. Nutrition, 103 (11): 1566–1580.Google Scholar
  11. 11.
    Sturman, J.A., 1979, Taurine in developing rat brain: Changes in blood-brain barrier, J. Neurochem, 32: 811–816.PubMedCrossRefGoogle Scholar
  12. 12.
    Sturman, J.A., Rassin, D.K., and Gaull, G.E., 1977, Taurine in developing rat brain: Transfer of (35S) taurine to pups via the milk, Pediat. Res, 11: 28–33.PubMedGoogle Scholar
  13. 13.
    Sturman, J.A., Rassin, D.K., and Gaull, G.E., 1977b, Taurine in developing rat brain: Maternal-fetal transfer of (35S) taurine and its fate in thè neonate, J. Neurochem, 28: 31–39.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Ryan J. Huxtable
    • 1
  • Shirley E. Lippincott
    • 1
  1. 1.Department of Pharmacology Health Sciences CenterUniversity of ArizonaTucsonUSA

Personalised recommendations